Hap Trading, LLC Athenex, Inc. Call Options Transaction History

Hap Trading, LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2021 Aug 11, 2021	SELL	$3.71 - $5.13 $42,294 - $58,482	-11,400 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$4.08 - $14.75 $14,688 - $53,100	-3,600 Reduced 24.0%	11,400 $3,000
Q3 2020 Nov 13, 2020	SELL	$10.26 - $14.55 $40,014 - $56,745	-3,900 Reduced 20.63%	15,000 $16,000
Q2 2020 Aug 10, 2020	BUY	$7.11 - $13.76 $49,059 - $94,944	6,900 Added 57.5%	18,900 $18,000
Q1 2020 May 08, 2020	BUY	$5.71 - $15.85 $68,520 - $190,200	12,000 New	12,000 $26,000

1.46M

Ticker ATNX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 156,790,000
Market Cap $1.57M
Description
Athenex, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of cancer. It operates through three segments: Oncology Innovation Platform, Global Supply Chain Platform, and Commercial Platform. The company's Orascovery product candidates include Oral paclitaxel and encequidar,...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.